Combined chemoimmunotherapy of solid tumours: improving vaccines?

Area of Science:

• Immunology
• Oncology
• Pharmacology

Background:

• Cytotoxic chemotherapy targets both tumors and lymphocytes, crucial for immune responses.
• Chemotherapy and immunotherapy have historically been viewed as conflicting treatment strategies.
• The mechanism of tumor cell death influences immune system interaction and response.

Purpose of the Study:

• To explore the complex interplay between chemotherapy and the immune system.
• To understand how chemotherapy affects immune cells, particularly lymphocytes and regulatory T cells.
• To identify opportunities for integrating immunotherapy with chemotherapy.

Main Methods:

• Review of cellular and immunological events in animal models and human patients undergoing chemotherapy.
• Analysis of how different chemotherapeutic drugs induce tumor cell death and immune interactions.
• Investigation of T cell depletion and subsequent homeostatic reconstitution.

Main Results:

• Chemotherapy's impact on tumor cell death dictates immune system interaction.
• Depletion of regulatory T cells by chemotherapy can enhance anti-tumor immunity.
• Lymphodepletion stimulates T cell reconstitution, creating a window for immune education.
• Post-chemotherapy immune reconstitution presents a therapeutic intervention opportunity.

Conclusions:

• Chemotherapy's effect on the immune system is multifaceted, offering potential for immunotherapy integration.
• Understanding chemotherapy-induced immunological changes is key to optimizing combination therapies.
• Strategic scheduling of immunomodulatory approaches with cytostatic drugs can enhance anti-tumor responses.